Retractable Technologies Inc (RVP)

Nov 16, 2024

Retractable Technologies reports loss of USD 5.1M in Q3 2024 - Medical Buyer

Nov 16, 2024

Nov 15, 2024

Retractable Technologies: Q3 Earnings Snapshot - New Haven Register

Nov 15, 2024

Nov 14, 2024

Retractable Technologies Inc (RVP) Quarterly 10-Q Report - Quartz

Nov 14, 2024

Nov 14, 2024

Retractable Technologies, Inc. Results for the Periods Ended September 30, 2024 - The Bakersfield Californian

Nov 14, 2024

Nov 14, 2024

Retractable Technologies Reports Steep Q3 Loss as Margins Collapse, Tariffs Bite | RVP Stock News - StockTitan

Nov 14, 2024

Nov 14, 2024

Retractable Technologies CEO Thomas Shaw acquires $5,422 in stock - Investing.com

Nov 14, 2024

Nov 14, 2024

Retractable Technologies CEO Thomas Shaw acquires $8,150 in stock By Investing.com - Investing.com Australia

Nov 14, 2024

Nov 13, 2024

RVP stock touches 52-week low at $0.7 amid market challenges - Investing.com

Nov 13, 2024

Nov 13, 2024

Retractable Technologies CEO Thomas Shaw acquires $8,150 in stock - Investing.com

Nov 13, 2024

Nov 13, 2024

Disposable Syringes Market Overall Study Report 2024-2031 | B. - openPR

Nov 13, 2024

Nov 12, 2024

Feds Can Hold Proceeds During Chinese Syringe Duties Fight - Law360

Nov 12, 2024

Nov 12, 2024

Retractable Technologies CEO Thomas J. Shaw acquires $6,876 in stock - Investing.com

Nov 12, 2024

Nov 11, 2024

Retractable Technologies (NYSE:RVP) Earns Hold Rating from Analysts at StockNews.com - Defense World

Nov 11, 2024

Nov 05, 2024

Head-To-Head Comparison: Neuronetics (NASDAQ:STIM) and Retractable Technologies (NYSE:RVP) - Defense World

Nov 05, 2024

Nov 04, 2024

Retractable Technologies CEO Thomas Shaw acquires $6,128 in stock - Investing.com

Nov 04, 2024

Nov 04, 2024

Retractable Technologies CEO Thomas Shaw acquires $6,128 in stock By Investing.com - Investing.com UK

Nov 04, 2024

Nov 02, 2024

Retractable Technologies stock hits 52-week low at $0.71 By Investing.com - Investing.com Australia

Nov 02, 2024

Nov 01, 2024

Retractable Technologies CEO Thomas Shaw buys shares for $429 - Investing.com

Nov 01, 2024

Nov 01, 2024

Retractable Technologies CEO Thomas Shaw buys shares for $429 By Investing.com - Investing.com Australia

Nov 01, 2024

Nov 01, 2024

Retractable Technologies stock hits 52-week low at $0.71 - Investing.com India

Nov 01, 2024

Oct 26, 2024

Retractable Technologies CEO Thomas Shaw buys $8,180 in stock By Investing.com - Investing.com Canada

Oct 26, 2024

Oct 25, 2024

Retractable Technologies CEO Thomas Shaw buys $8,180 in stock - Investing.com

Oct 25, 2024

Oct 24, 2024

Retractable Technologies CEO Thomas Shaw acquires $15,661 in stock - Investing.com

Oct 24, 2024

Oct 24, 2024

Retractable Technologies CEO Thomas Shaw acquires $15,661 in stock By Investing.com - Investing.com Australia

Oct 24, 2024

Oct 21, 2024

Retractable Technologies CEO Shaw buys $6,061 in stock By Investing.com - Investing.com South Africa

Oct 21, 2024

Oct 21, 2024

Retractable Technologies CEO Shaw buys $6,061 in stock - Investing.com

Oct 21, 2024

Oct 17, 2024

Safety Syringes Market 2024-2031 Global Industry Analysis, - openPR

Oct 17, 2024

Oct 17, 2024

Smart Syringes Market Projected to Surge to USD 143.93 Million by 2031 - WhaTech

Oct 17, 2024

Oct 16, 2024

Retractable Technologies CEO Thomas J. Shaw acquires $4,632 in stock - Investing.com India

Oct 16, 2024

Oct 15, 2024

Retractable Technologies CEO Thomas J. Shaw acquires $4,632 in stock By Investing.com - Investing.com South Africa

Oct 15, 2024

Oct 15, 2024

Hypodermic Needles Market Generated Opportunities, Future - openPR

Oct 15, 2024

Oct 08, 2024

Venous Blood Collection Market to Witness Huge Growth by 2032 |Terumo, BD, Bio Rad Laboratories, Nipro - openPR

Oct 08, 2024

Oct 07, 2024

Retractable sues Becton alleging patent infringement - Reuters

Oct 07, 2024

Oct 07, 2024

Disposable Syringes Market Forecasting Dynamic Growth: - openPR

Oct 07, 2024

Oct 07, 2024

Smart Syringes Industry: Insights from Latest Research Report on Business Opportunities by (2024-2034) - IndiaPolitics.com

Oct 07, 2024

Oct 04, 2024

U.S. Disposable Syringes Market Analysis 2024-2030: Rising Vaccine Demand and Growing Adoption of - Daily Guardian Canada

Oct 04, 2024

Oct 04, 2024

U.S. Disposable Syringes Market Analysis 2024-2030: Rising - GlobeNewswire

Oct 04, 2024

Oct 04, 2024

U.S. Disposable Syringes Market Analysis 2024-2030: Rising Vaccine Demand and Growing Adoption of Self-Administered Drug Solutions - Yahoo Finance

Oct 04, 2024

Oct 02, 2024

Retractable technologies CEO buys $4.3k of company stock - Investing.com

Oct 02, 2024

Oct 02, 2024

Retractable technologies CEO buys $4.3k of company stock By Investing.com - Investing.com UK

Oct 02, 2024

Oct 02, 2024

Disposable Syringes Market 2024 Business Development, Size, Share and Opportunities 2033 - Cauverynews

Oct 02, 2024

Sep 30, 2024

Retractable Technologies, Inc. Declares Dividends to Series II and III Class B Preferred Stock Shareholders - Post Register

Sep 30, 2024

Sep 30, 2024

Retractable Technologies, Inc. Files Complaint in United States Court of International Trade - StockTitan

Sep 30, 2024